Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 12 | N/A | 1 | N/A |
| Other current assets | 178 | 238 | 0 | 0 | 0 |
| TOTAL | $190 | $284 | $N/A | $79 | $7 |
| Non-Current Assets | |||||
| PPE Net | 10 | 12 | N/A | 14 | 15 |
| Other Non-Current Assets | 0 | 0 | 0 | 286 | 0 |
| TOTAL | $10 | $12 | $N/A | $300 | $15 |
| Total Assets | $201 | $295 | $N/A | $379 | $22 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 161 | 134 | 0 | 160 | 163 |
| Accrued Expenses | 47 | 32 | N/A | 19 | 20 |
| TOTAL | $442 | $392 | $N/A | $206 | $243 |
| Non-Current Liabilities | |||||
| Long Term Debt | 247 | 196 | N/A | 450 | 3 |
| Other Non-Current Liabilities | 656 | 633 | 0 | 607 | 711 |
| TOTAL | $903 | $829 | $N/A | $1,057 | $714 |
| Total Liabilities | $1,345 | $1,221 | $N/A | $1,263 | $957 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,093 | 32,858 | 27,710 | 25,347 | 18,083 |
| Common Shares | 341 | 277 | N/A | 42 | -88 |
| Retained earnings | -18,916 | -18,565 | N/A | -18,227 | -18,057 |
| Other shareholders' equity | -2,473 | -1,037 | 0 | -890 | -13 |
| TOTAL | $-1,145 | $-925 | $N/A | $-884 | $-935 |
| Total Liabilities And Equity | $201 | $295 | $0 | $379 | $22 |